Balloon pump support for early cardiogenic shock
Part of Heart & circulation clinical trials.
This trial is testing a device called an intra-aortic balloon pump (IABP) to help support the heart in people with cardiogenic shock. You may be eligible if you are in the early stages of shock and have not needed too many strong medicines yet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with cardiogenic shock (a condition where the heart can't pump enough blood) at a specific stage (B or C)
- You have at least one abnormal lab result (like high lactate, worse kidney function, liver markers, or high NT-proBNP)
- You are on at most one medicine to support your heart function or blood pressure
- You are not on a high dose of norepinephrine (a blood pressure medicine) and your blood pressure is above 65 mmHg
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how well the heart's pumping is helped by using an intra-aortic balloon pump, a device inserted to support blood flow in people with cardiogenic shock. It aims to learn more about how the device works and improve care.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This trial tests whether using a temporary heart pump plus close monitoring improves recovery in people with severe heart failure after a heart attack, compared to standard care.
This trial tests a new heart pump (Impella device) for people who have a severe heart attack and go into shock (very low blood pressure). It aims to see if the pump can help the heart recover better than standard care.
This trial studies whether putting in a small heart pump early (through the leg) helps people with a heart attack complicated by severe heart weakness (“cardiogenic shock”) compared with standard treatment. It aims to improve survival and recovery by supporting blood flow sooner.
This trial is testing a temporary heart pump device that helps your heart pump blood when it's too weak to do its job. It's for people who have severe heart failure (cardiogenic shock) despite getting powerful medications to keep their heart working.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.